Epidemiology of Cervical, Vulvar, and Vaginal Cancers

Gynecologic Cancer: Controversies in Management

Volumn , Issue , 2004, Pages 3-30

  Tortolero Luna, Guillermo ^a,b   Franco, Eduardo L ^c,d  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d Fonds de la Recherche en Sante du Quebec   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902218604     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-07142-3.50005-1     Document Type: Chapter

References (287)

1. AP Vizcaino, V Moreno, FX Bosch, et al. (2000) International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 86 429-435.
2. D Solomon, M Schiffman and R Tarone (2002) ASCUS LSIL Triage Study (ALTS) conclusions reaffirmed: Response to a November 2001 commentary. Obstet Gynecol 99 671-674.
3. IARC Working Group (1995) Human Papillomaviruses. (64). IARC Monographs on the Evaluation of Carcinogenic Risks to Human Lyon, France: International Agency for Research on Cancer
4. JM Walboomers, MV Jacobs, MM Manos, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide [comment]. J Pathol 189 12-19.
5. FX Bosch and S de SanJose (2003) Human papillomavirus and cervical cancer: Burden and assessment of causality [review]. J Natl Cancer Inst Monogr (31), 3-13.
6. DM Parkin, FI Bray and SS Devesa (2001) Cancer burden in the year 2000: The global picture. Eur J Cancer 37(Suppl 8), S4-S66.
7. DM Parkin (2001) Global cancer statistics in the year 2000. Lancet 2 533-543.
8. A Jemal, T Murray, A Samuels, et al. (2003) Cancer statistics, 2003. CA Cancer J Clin 53 5-26.
9. R Sankaranarayanan, AM Budukh and R Rajkumar (2001) Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 79 954-962.
10. EL Franco, E Duarte-Franco and A Ferenczy (2001) Cervical cancer: Epidemiology, prevention and the role of human papillomavirus infection [comment]. CMAJ 164 1017-1025.
11. J Ferlay, F Bray, P Pisani and DM Parkin (2001) GLOBOCAN 2000: Cancer Incidence, Mortality, and Prevalence Worldwide, Version 1.0. IARC CancerBase No. 5 Lyon, France: International Agency for Research on Cancer
12. EL Franco (2003) Primary screening of cervical cancer with human papillomavirus tests [review]. J Natl Cancer Inst Monogr (31), 89-96.
13. V Beral, C Hermon, N Munoz and SS Devesa (1994) Cervical cancer. Cancer Surv 19-20 265-285.
14. EL Franco and A Ferenczy (2002) Cervix. EL Franco, T Rohan (Eds) Cancer Precursors: Epidemiology, Detection, and Prevention New York: Springer-Verlag
15. AP Vizcaino, V Moreno, FX Bosch, et al. (1998) International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 75 536-545.
16. EL Franco, E Duarte-Franco and TE Rohan (2002) Evidence-based policy recommendations on cancer screening and prevention [review]. Cancer Detect Prev 26 350-361.
17. LAG Ries, MP Eisner, CL Kosary, et al. (2003) SEER Cancer Statistics Review, 1975-2000 Bethesda, MD: National Cancer Institute
18. BA Miller, LN Kolonel, LN Kolonel, et al. (1996) Racial/Ethnic Patterns of Cancer in the United States 1988-1992. (NIH Pub. No. 96-4140) Bethesda, MD: National Cancer Institute
19. MH Schiffman, LA Brinton, SS Devessa and FM Fraumeni (1996) Cervical cancer. D Schottenfeld, JF Fraumeni (Eds) Cancer Epidemiology and Prevention New York: Oxford University Press
20. S Parikh, P Brennan and P Boffetta (2003) Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer 105 687-691.
21. PK Drain, KK Holmes, JP Hughes and LA Koutsky (2002) Determinants of cervical cancer rates in developing countries. Int J Cancer 100 199-205.
22. GK Singh, BA Miller, BF Hankey and BK Edwards (2003) Area Socioeconomic Variations in U. S. Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975-1999. NCI Cancer Surveillance Monograph Series, Number 4. (NIH Publication No. 03-5417) Bethesda, MD: National Cancer Institute
23. KM Gorey, EJ Holowary, G Fehringer, et al. (1997) An international comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan, metropolitan areas. Am J Public Health 87 1156-1163.
24. LA Brinton (1992) Epidemiology of cervical cancer: Overview. N Muñoz, FX Bosch, KV Shah, A Meheus (Eds) The Epidemiology of Human Papillomavirus and Cervical Cancer Lyon, France: International Agency for Research on Cancer 3-23.
25. DC Boyle and JR Smith (1999) Infection and cervical intraepithelial neoplasia. Int J Gynecol Cancer 9 177-186.
26. FX Bosch and N Munoz (2002) The viral etiology of cervical cancer [review]. Virus Res 89 183-190.
27. H zur Hausen (1977) Human papillomaviruses and their possible role in squamous cell carcinomas [review]. Curr Top Microbiol Immunol 78 1-30.
28. LA Koutsky, KK Holmes, CW Critchlow, et al. (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327 1272-1278.
29. MA Nobbenhuis, JM Walboomers, TJ Helmerhorst, et al. (1999) Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study. Lancet 354 20-25.
30. G Tortolero-Luna, MF Mitchell, DC Swan, et al. (1998) A case-control study of human papillomavirus and cervical squamous intraepithelial lesions (SIL) in Harris County, Texas: Differences among racial/ethnic groups. Cad de Saude Publica 14(Suppl 3), 149-159.
31. GY Ho, R Bierman, L Beardsley, et al. (1998) Natural history of cervico-vaginal papillomavirus infection in young women. N Engl J Med 338 423-428.
32. AB Moscicki, N Hills, S Shiboski, et al. (2001) Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 285 2995-3002.
33. N Munoz (2000) Human papillomavirus and cancer: The epidemiological evidence [review]. J Clin Virol 19 1-5.
34. FX Bosch, A Lorincz, N Munoz, et al. (2002) The causal relation between human papillomavirus and cervical cancer [comment] [review]. J Clin Pathol 55 244-265.
35. LA Koutsky (1997) Epidemiology of genital human papillomavirus infection [review]. Am J Med 102 3-8.
36. N Munoz, FX Bosch, S de SanJose, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer [comment]. N Engl J Med 348 518-527.
37. FX Bosch, MM Manos, N Munoz, et al. (1995) Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group [see comments]. J Natl Cancer Inst 87 796-802.
38. EA Morrison, GY Ho, SH Vermund, et al. (1991) Human papillomavirus infection and other risk factors for cervical neoplasia: A case-control study [comment]. Int J Cancer 49 6-13.
39. FX Bosch, N Munoz, S de SanJose, et al. (1993) Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: A case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 2 415-422.
40. SK Kjaer (1998) Risk factors for cervical neoplasia in Denmark. APMIS Suppl 80 1-41.
41. GM Clifford, JS Smith, M Plummer, et al. (2003) Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 88 63-73.
42. DC Swan, RA Tucker, G Tortolero-Luna, et al. (1999) Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 37 1030-1034.
43. A Hildesheim and SS Wang (2002) Host and viral genetics and risk of cervical cancer: A review [review]. Virus Res 89 229-240.
44. SS Wang and A Hildesheim (2003) Viral and host factors in human papillomavirus persistence and progression [review]. J Natl Cancer Inst Monogr (31), 35-40.
45. EL Franco, TE Rohan and LL Villa (1999) Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 91 506-511.
46. S Wacholder (2003) Statistical issues in the design and analysis of studies of human papillomavirus and cervical neoplasia [review]. J Natl Cancer Inst Monogr (31), 125-130.
47. X Castellsague and N Munoz (2003) Cofactors in human papillomavirus carcinogenesis: Role of parity, oral contraceptives, and tobacco smoking [review]. J Natl Cancer Inst Monogr (31), 20-28.
48. N Potischman and LA Brinton (1996) Nutrition and cervical neoplasia [review] [erratum appears in Cancer Causes Control 1996;7:402.]. Cancer Causes Control 7 113-126.
49. GY Ho, AS Kadish, RD Burk, et al. (1998) HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer 78 281-285.
50. V Moreno, FX Bosch, N Munoz, et al. (2002) Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric case-control study [comment]. Lancet 359 1085-1092.
51. M Schiffman and SK Kjaer (2003) Natural history of anogenital human papillomavirus infection and neoplasia [review]. J Natl Cancer Inst Monogr (31), 14-19.
52. PE Castle and AR Giuliano (2003) Genital tract infections, cervical inflammation, and antioxidant nutrients: Assessing their roles as human papillomavirus cofactors [review]. J Natl Cancer Inst Monogr (31), 29-34.
53. PC Maciag, NF Schlecht, PS Souza, et al. (2000) Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 9 1183-1191.
54. H Makni, EL Franco, J Kaiano, et al. (2000) P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: Effect of inter-laboratory variation. Int J Cancer 87 528-533.
55. Koushik A, Franco E, Platt RW: P53 codon 72 polymorphism and cervical neoplasia: A review. Cancer Epidemiol Biomarkers Prev (in press).
56. JS Smith, J Green, DG Berrington, et al. (2003) Cervical cancer and use of hormonal contraceptives: A systematic review [review] [comment]. Lancet 361 1159-1167.
57. N Ylitalo, P Sorensen, AM Josefsson, et al. (2000) Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: A nested case-control study [comment]. Lancet 355 2194-2198.
58. M Zerbini, S Venturoli, M Cricca, et al. (2001) Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCR-ELISA. J Clin Pathol 54 377-380.
59. AT Lorincz, PE Castle, ME Sherman, et al. (2002) Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360 228-229.
60. MH Schiffman and P Castle (2003) Epidemiologic studies of a necessary causal risk factor: Human papilllomavirus infection and cervical neoplasia. J Natl Cancer Inst 95 E2.
61. R Herrero, LA Brinton, WC Reeves, et al. (1990) Risk factors for invasive carcinoma of the uterine cervix in Latin America. Bull Pan Am Health Organ 24 263-283.
62. MH Schiffman, HM Bauer, RN Hoover, et al. (1993) Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia [see comments]. J Natl Cancer Inst 85 958-964.
63. J Eluf-Neto (1994) Number of sexual partners and smoking behaviour as risk factors for cervical dysplasia: Comments on the evaluation of interaction [letter; comment]. Int J Epidemiol 23 1101-1104.
64. H Yoshikawa, C Nagata, K Noda, et al. (1999) Human papillomavirus infection and other risk factors for cervical intraepithelial neoplasia in Japan. Br J Cancer 80 621-624.
65. X Castellsague, FX Bosch and N Munoz (2002) Environmental co-factors in HPV carcinogenesis [review]. Virus Res 89 191-199.
66. N Munoz, S Franceschi, C Bosetti, et al. (2002) Role of parity and human papillomavirus in cervical cancer: The IARC multicentric case-control study [comment]. Lancet 359 1093-1101.
67. N Munoz, FX Bosch, S de SanJose, et al. (1993) Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 2 423-431.
68. A Hildesheim, R Herrero, PE Castle, et al. (2001) HPV co-factors related to the development of cervical cancer: Results from a population-based study in Costa Rica. Br J Cancer 84 1219-1226.
69. S Kruger-Kjaer, AJ Van den Brule, EI Svare, et al. (1998) Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women. Int J Cancer 76 613-619.
70. JM Deacon, CD Evans, R Yule, et al. (2000) Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: A case-control study nested within the Manchester cohort. Br J Cancer 83 1565-1572.
71. PE Castle, S Wacholder, AT Lorincz, et al. (2002) A prospective study of high-grade cervical neoplasia risk among human papillo-mavirus-infected women. J Natl Cancer Inst 94 1406-1414.
72. M Moodley, J Moodley, R Chetty and CS Herrington (2003) The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: A review [review]. Int J Gynecol Cancer 13 103-110.
73. EM de Villiers (2003) Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma [review]. Int J Cancer 103 705-708.
74. LA Brinton (1991) Oral contraceptives and cervical neoplasia. Contraception 43 581-595.
75. M Delgado-Rodriguez, M Sillero-Arenas, JM Martin-Moreno and R Galvez-Vargas (1992) Oral contraceptives and cancer of the cervix uteri: A meta-analysis. Acta Obstet Gynecol Scand 71 368-376.
76. FX Bosch, N Munoz, S de SanJose, et al. (1992) Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 52 750-758.
77. AO Olsen, K Gjen, T Sauer, et al. (1995) Human papillomavirus and cervical intraepithelial neoplasia grade II-III: A population-based case-control study. Int J Cancer 61 312-315.
78. JV Lacey Jr, LA Brinton, FM Abbas, et al. (1999) Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 8(12), 1079-1085.
79. BP Negrini, MH Schiffman, RJ Kurman, et al. (1990) Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix. Cancer Res 50 4670-4675.
80. JV Lacey Jr, CA Swanson, LA Brinton, et al. (2003) Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 98 814-821.
81. J Green, DG Berrington, JS Smith, et al. (2003) Human papillomavirus infection and use of oral contraceptives [review]. Br J Cancer 88 1713-1720.
82. W Winkelstein Jr (1986) Cigarette smoking and cancer of the uterine cervix. Banbury Rep 23 329-341.
83. AN Phillips and GD Smith (1994) Cigarette smoking as a potential cause of cervical cancer: Has confounding been controlled? [see comments]. Int J Epidemiol 23 42-49.
84. F Parazzini, L Chatenoud, C La Vecchia, et al. (1998) Determinants of risk of invasive cervical cancer in young women. Br J Cancer 77 838-841.
85. TM Becker, CM Wheeler, NS McGough, et al. (1994) Cigarette smoking and other risk factors for cervical dysplasia in southwestern Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 3 113-119.
86. JR Daling, MM Madeleine, B McKnight, et al. (1996) The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev 5 541-548.
87. SK Kjaer, G Engholm, C Dahl and JE Bock (1996) Case-control study of risk factors for cervical squamous cell neoplasia in Denmark. IV: Role of smoking habits. Eur J Cancer Prev 5 359-365.
88. PA Kanetsky, MD Gammon, J Mandelblatt, et al. (1998) Cigarette smoking and cervical dysplasia among non-Hispanic black women. Cancer Detect Prev 22 109-119.
89. AO Olsen, J Dillner, A Skrondal and P Magnus (1998) Combined effect of smoking and human papillomavirus type 16 infection in cervical carcinogenesis. Epidemiology 9 346-349.
90. CM Roteli-Martins, K Panetta, VA Alves, et al. (1998) Cigarette smoking and high-risk HPV DNA as predisposing factors for high-grade cervical intraepithelial neoplasia (CIN) in young Brazilian women. Acta Obstet Gynecol Scand 77 678-682.
91. MH Schiffman, NJ Haley, JS Felton, et al. (1987) Biochemical epidemiology of cervical neoplasia: Measuring cigarette smoke constituents in the cervix. Cancer Res 47 3886-3888.
92. D Hellberg, S Nilsson, NJ Haley, et al. (1988) Smoking and cervical intraepithelial neoplasia: Nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am J Obstet Gynecol 158 910-913.
93. WA Poppe, R Peeters, P Daenens, et al. (1995) Tobacco smoking and the uterine cervix: Cotinine in blood, urine and cervical fluid. Gynecol Obstet Invest 39 110-114.
94. B Prokopczyk, JE Cox, D Hoffmann and SE Waggoner (1997) Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 89 868-873.
95. J Cuzick, A Singer, BL De Stavola and J Chomet (1990) Case-control study of risk factors for cervical intraepithelial neoplasia in young women. Eur J Cancer 26 684-690.
96. DH Phillips and MN She (1994) DNA adducts in cervical tissue of smokers and non-smokers. Mutat Res 313 277-284.
97. AM Simons, C Mugica van Herckenrode, JA Rodriguez, et al. (1995) Demonstration of smoking-related DNA damage in cervical epithelium and correlation with human papillomavirus type 16, using exfoliated cervical cells. Br J Cancer 71 246-249.
98. EM Cerqueira, CL Santoro, NF Donozo, et al. (1998) Genetic damage in exfoliated cells of the uterine cervix: Association and interaction between cigarette smoking and progression to malignant transformation? Acta Cytol 42 639-649.
99. WA Poppe, PS Ide, MP Drijkoningen, et al. (1995) Tobacco smoking impairs the local immunosurveillance in the uterine cervix: An immunohistochemical study. Gynecol Obstet Invest 39 34-38.
100. A Szarewski, MJ Jarvis, P Sasieni, et al. (1996) Effect of smoking cessation on cervical lesion size [comment]. Lancet 347 941-943.
101. NN Acladious, C Sutton, D Mandal, et al. (2002) Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN). Int J Cancer 98 435-439.
102. AR Giuliano, R Harris, RL Sedjo, et al. (2002) Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis 186 462-469.
103. JV Lacey Jr, M Frisch, LA Brinton, et al. (2001) Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control 12 153-161.
104. EL Franco (1991) Viral etiology of cervical cancer: A critique of the evidence [review]. Rev Infect Dis 13 1195-1206.
105. H Zur Hausen (1982) Human genital cancer: Synergism between two virus infections or synergism between a virus infection and initiating events? Lancet 2 1370-1372.
106. DA Galloway and JK McDougall (1983) The oncogenic potential of herpes simplex viruses: Evidence for a “hit-and-run” mechanism. Nature 302 21-24.
107. JA Dipaolo, CD Woodworth, F Coutlee, et al. (1998) Relationship of stable integration of herpes simplex virus-2 Bg/II N subfragment Xho2 to malignant transformation of human papillomavirus-immortalized cervical keratinocytes. Int J Cancer 76 865-871.
108. D Tran-Thanh, D Provencher, A Koushik, et al. (2003) Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix. Am J Obstet Gynecol 188 129-134.
109. S de SanJose, N Munoz, FX Bosch, et al. (1994) Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer 56 358-363.
110. J Dillner, P Lenner, M Lehtinen, et al. (1994) A population-based seroepidemiological study of cervical cancer. Cancer Res 54 134-141.
111. PK Jha, V Beral, J Peto, et al. (1993) Antibodies to human papillomavirus and other genital infectious agents and invasive cervical cancer risk. Lancet 341 1116-1118.
112. HQ Peng, SL Liu, V Mann, et al. (1991) Human papillomavirus types 16 and 33, herpes simplex virus type 2 and other risk factors for cervical cancer in Sichuan Province, China. Int J Cancer 47 711-716.
113. TM Becker, CM Wheeler, NS McGough, et al. (1994) Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA 271 1181-1188.
114. A Ferrera, MF Baay, P Herbrink, et al. (1997) A sero-epidemiological study of the relationship between sexually transmitted agents and cervical cancer in Honduras. Int J Cancer 73 781-785.
115. DB Thomas, RM Ray, A Koetsawang, et al. (2001) Human papillo-maviruses and cervical cancer in Bangkok. I: Risk factors for invasive cervical carcinomas with human papillomavirus types 16 and 18 DNA. Am J Epidemiol 153 723-731.
116. M Lehtinen, P Koskela, E Jellum, et al. (2002) Herpes simplex virus and risk of cervical cancer: A longitudinal, nested case-control study in the nordic countries. Am J Epidemiol 156 687-692.
117. JS Smith, R Herrero, C Bosetti, et al. (2002) Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer [comment]. J Natl Cancer Inst 94 1604-1613.
118. P Koskela, T Anttila, T Bjorge, et al. (2000) Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 85 35-39.
119. T Anttila, P Saikku, P Koskela, et al. (2001) Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma [comment]. JAMA 285 47-51.
120. KL Wallin, F Wiklund, T Luostarinen, et al. (2002) A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer 101 371-374.
121. JS Smith, N Munoz, R Herrero, et al. (2002) Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 185 324-331.
122. MP Burger, H Hollema, WJ Pieters, et al. (1996) Epidemiological evidence of cervical intraepithelial neoplasia without the presence of human papillomavirus. Br J Cancer 73 831-836.
123. EC Claas, WJ Melchers, HG Niesters, et al. (1992) Infections of the cervix uteri with human papillomavirus and Chlamydia trachomatis. J Med Virol 37 54-57.
124. Centers for Disease Control and Prevention (1993) Revised classification system for HIV infection and expanded surveillance definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41 1-15.
125. BN Lee, M Follen, G Tortolero-Luna, et al. (1999) Synthesis of IFN-gamma by CD8(+) T cells is preserved in HIV-infected women with HPV-related cervical squamous intraepithelial lesions. Gynecol Oncol 75 379-386.
126. N Jay and AB Moscicki (2000) Human papillomavirus infections in women with HIV disease: Prevalence, risk, and management [review]. AIDS Reader 10 659-668.
127. LJ Conley, TV Ellerbrock, TJ Bush, et al. (2002) HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: A prospective cohort study [comment]. Lancet 359 108-113.
128. CL Langley, E Benga-De, CW Critchlow, et al. (1996) HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women. AIDS 10 413-417.
129. M Maiman, RG Fruchter, A Sedlis, et al. (1998) Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol 68 233-239.
130. LS Massad, KA Riester, KM Anastos, et al. (1999) Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defici Syndr Hum Retrovirol 21 33-41.
131. TV Ellerbrock, MA Chiasson, TJ Bush, et al. (2000) Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 283 1031-1037.
132. AB Moscicki, JH Ellenberg, SH Vermund, et al. (2000) Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: Impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med 154 127-134.
133. A Ferenczy, F Coutlee, E Franco and C Hankins (2003) Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: A review of recent developments [review]. CMAJ 169 431-434.
134. JS Mandelblatt, P Kanetsky, L Eggert and K Gold (1999) Is HIV infection a cofactor for cervical squamous cell neoplasia? [comment]. Cancer Epidemiol Biomarkers Prev 8 97-106.
135. G La Ruche, V Leroy, I Mensah-Ado, et al. (1999) Short-term follow up of cervical squamous intraepithelial lesions associated with HIV and human papillomavirus infections in Africa. Int J STD AIDS 10 363-368.
136. S de SanJose and J Palefsky (2002) Cervical and anal HPV infections in HIV positive women and men [review]. Virus Res 89 201-211.
137. A Schneider and K Shah (1989) The role of vitamins in the etiology of cervical neoplasia: An epidemiological review [review]. Arch Gynecol Obstet 246 1-13.
138. CE Butterworth Jr, KD Hatch, SJ Soong, et al. (1992) Oral folic acid supplementation for cervical dysplasia: A clinical intervention trial. Am J Obstet Gynecol 166 803-809.
139. AR Giuliano (2000) The role of nutrients in the prevention of cervical dysplasia and cancer [review]. Nutrition 16 570-573.
140. RG Ziegler, LA Brinton, RF Hamman, et al. (1990) Diet and the risk of invasive cervical cancer among white women in the United States. Am J Epidemiol 132 432-445.
141. RG Ziegler, CJ Jones, LA Brinton, et al. (1991) Diet and the risk of in situ cervical cancer among white women in the United States. Cancer Causes Control 2 17-29.
142. J Van Eenwyk, FG Davis and PE Bowen (1991) Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer 48 34-38.
143. J Van Eenwyk, FG Davis and N Colman (1992) Folate, vitamin C, and cervical intraepithelial neoplasia [see comments]. Cancer Epidemiol Biomarkers Prev 1 119-124.
144. T Liu, SJ Soong, NP Wilson, et al. (1993) A case control study of nutritional factors and cervical dysplasia. Cancer Epidemiol Biomarkers Prev 2 525-530.
145. AM Batieha, HK Armenian, EP Norkus, et al. (1993) Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study. Cancer Epidemiol Biomarkers Prev 2 335-339.
146. N Potischman (1993) Nutritional epidemiology of cervical neoplasia [review]. J Nutr 123(2 Suppl), 424-429.
147. L Wideroff, N Potischman, AG Glass, et al. (1998) A nested case-control study of dietary factors and the risk of incident cyto-logical abnormalities of the cervix. Nutr Cancer 30 130-136.
148. RL Sedjo, P Inserra, M Abrahamsen, et al. (2002) Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiol Biomarkers Prev 11 353-359.
149. RL Sedjo, DJ Roe, M Abrahamsen, et al. (2002) Vitamin A, carotenoids, and risk of persistent oncogenic human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 11 876-884.
150. AR Giuliano, EM Siegel, D Roe, et al. (2003) Dietary intake and risk of persistent human papillomavirus (HPV) infection: The Ludwig-McGill HPV natural history study. J Infect Dis 188 1508-1516.
151. AB Moscicki, S Shiboski, J Broering, et al. (1998) The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 132 277-284.
152. EL Franco, LL Villa, JP Sobrinho, et al. (1999) Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 180 1415-1423.
153. KK Thomas, JP Hughes, JM Kuypers, et al. (2000) Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 182 1097-1102.
154. KL Liaw, A Hildesheim, RD Burk, et al. (2001) A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 183 8-15.
155. J Konya and J Dillner (2001) Immunity to oncogenic human papillo-maviruses [review]. Adv Cancer Res 82 205-238.
156. M Scott, M Nakagawa and AB Moscicki (2001) Cell-mediated immune response to human papillomavirus infection [review]. Clin Diagn Lab Immunol 8 209-220.
157. J Dillner, A Andersson-Ellstrom, B Hagmar and J Schiller (1999) High risk genital papillomavirus infections are not spread vertically [review]. Rev Med Virol 9 23-29.
158. TD de Gruijl, HJ Bontkes, JM Walboomers, et al. (1997) Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. J Natl Cancer Inst 89 630-638.
159. L Wideroff, M Schiffman, P Haderer, et al. (1999) Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions. J Infect Dis 180 1424-1428.
160. Y Sun, J Eluf-Neto, FX Bosch, et al. (1999) Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma. Cancer Epidemiol Biomarkers Prev 8 935-940.
161. ME Hagensee, LA Koutsky, SK Lee, et al. (2000) Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions. J Infect Dis 181 1234-1239.
162. M Lehtinen, M Pawlita, K Zumbach, et al. (2003) Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. Am J Obstet Gynecol 188 49-55.
163. JJ Carter, LA Koutsky, JP Hughes, et al. (2000) Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 181 1911-1919.
164. S Sukvirach, JS Smith, S Tunsakul, et al. (2003) Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 187 1246-1256.
165. K Heim, A Widschwendter, G Pirschner, et al. (2002) Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer. Am J Obstet Gynecol 186 705-711.
166. K Matsumoto, T Yasugi, A Oki, et al. (2003) Are smoking and chlamydial infection risk factors for CIN? Different results after adjustment for HPV DNA and antibodies. Br J Cancer 89 831-833.
167. RP Viscidi, L Ahdieh-Grant, B Clayman, et al. (2003) Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis 187 194-205.
168. B Nonnenmacher, J Pintos, MC Bozzetti, et al. (2003) Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer. Int J STD AIDS 14 258-265.
169. GY Ho, Y Studentsov, CB Hall, et al. (2002) Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles. J Infect Dis 186 737-742.
170. LA Koutsky, KA Ault, CM Wheeler, et al. (2002) A controlled trial of a human papillomavirus type 16 vaccine [comment]. N Engl J Med 347 1645-1651.
171. MY Tjiong, TA Out, J ter Schegget, et al. (2001) Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract: A review [review]. Int J Gynecol Cancer 11 9-17.
172. Z Wang, BG Hansson, O Forslund, et al. (1996) Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA. J Clin Microbiol 34 3056-3062.
173. T Sasagawa, RC Rose, KK Azar, et al. (2003) Mucosal immunoglobulin-A and -G responses to oncogenic human papilloma virus capsids. Int J Cancer 104 328-335.
174. L Rocha-Zavaleta, AL Pereira-Suarez, G Yescas, et al. (2003) Mucosal IgG and IgA responses to human papillomavirus type 16 capsid proteins in HPV16-infected women without visible pathology. Viral Immunol 16 159-168.
175. M Nakagawa, DP Stites, S Farhat, et al. (1996) T-cell proliferative response to human papillomavirus type 16 peptides: Relationship to cervical intraepithelial neoplasia. Clin Diagn Lab Immunol 3 205-210.
176. C Benton, H Shahidullah and JAA Hunter (1992) Human papillomavirus in the immunosuppressed. Papillomavirus Report 3 23-36.
177. T Tsukui, A Hildesheim, MH Schiffman, et al. (1996) Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: Correlation with cervical pathology. Cancer Res 56 3967-3974.
178. K Iwatsuki, H Tagami, M Takigawa and M Yamada (1986) Plane warts under spontaneous regression: Immunopathologic study on cellular constituents leading to the inflammatory reaction. Arch Dermatol 122 655-659.
179. SK Tay, D Jenkins, P Maddox, et al. (1987) Subpopulations of Langerhans' cells in cervical neoplasia. Br J Obstet Gynaecol 94 10-15.
180. RJ Apple, HA Erlich, W Klitz, et al. (1994) HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 6 157-162.
181. K Odunsi, G Terry, L Ho, et al. (1995) Association between HLA DQB1*03 and cervical intra-epithelial neoplasia. Mol Med 1 161-171.
182. A Sher, RT Gazzinelli, IP Oswald, et al. (1992) Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection [review]. Immunol Rev 127 183-204.
183. M Yamamura, K Uyemura, RJ Deans, et al. (1991) Defining protective responses to pathogens: Cytokine profiles in leprosy lesions [erratum appears in Science 1992;255:12]. Science 254 277-279.
184. M Clerici and GM Shearer (1994) The Th1-Th2 hypothesis of HIV infection: New insights [review]. Immunol Today 15 575-581.
185. TD de Gruijl, HJ Bontkes, JM Walboomers, et al. (1999) Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I: Differential T-helper and IgG responses in relation to HPV infection and disease outcome. J Gen Virol 80 399-408.
186. TD de Gruijl, HJ Bontkes, AJ van den Muysenberg, et al. (1999) Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix. Eur J Cancer 35 490-497.
187. M Nakagawa, DP Stites, S Farhat, et al. (1997) Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: Relationship to cervical intraepithelial neoplasia. J Infect Dis 175 927-931.
188. M Clerici, M Merola, E Ferrario, et al. (1997) Cytokine production patterns in cervical intraepithelial neoplasia: Association with human papillomavirus infection [see comments]. J Natl Cancer Inst 89 245-250.
189. AS Kadish, GY Ho, RD Burk, et al. (1997) Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: Outcome of HPV infection and associated neoplasia. J Natl Cancer Inst 89 1285-1293.
190. AS Kadish, P Timmins, Y Wang, et al. (2002) Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomarkers Prev 11 483-488.
191. TD de Gruijl, HJ Bontkes, JM Walboomers, et al. (1998) Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: A longitudinal study. Cancer Res 58 1700-1706.
192. K Odunsi, G Terry, L Ho, et al. (1996) Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles. Int J Cancer 67 595-602.
193. F Breitburd, N Ramoz, J Salmon and G Orth (1996) HLA control in the progression of human papillomavirus infections [review]. Semin Cancer Biol 7 359-371.
194. KO Odunsi and TS Ganesan (1997) The roles of the human major histo-compatibility complex and human papillomavirus infection in cervical intraepithelial neoplasia and cervical cancer [review]. Clin Oncol (R Coll Radiol) 9 4-13.
195. A Helland, AO Olsen, K Gjoen, et al. (1998) An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: A population-based case-control study of Norwegian women. Int J Cancer 76 19-24.
196. A Hildesheim, M Schiffman, DR Scott, et al. (1998) Human leukocyte antigen class I/II alleles and development of human papillo-mavirus-related cervical neoplasia: Results from a case-control study conducted in the United States. Cancer Epidemiol Biomarkers Prev 7 1035-1041.
197. RJ Apple, TM Becker, CM Wheeler and HA Erlich (1995) Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J Natl Cancer Inst 87 427-436.
198. CB Sanjeevi, P Hjelmstrom, G Hallmans, et al. (1996) Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women. Int J Cancer 68 409-414.
199. MM Madeleine, B Brumback, KL Cushing-Haugen, et al. (2002) Human leukocyte antigen class II and cervical cancer risk: A population-based study. J Infect Dis 186 1565-1574.
200. RW Harris, D Forman, R Doll, et al. (1986) Cancer of the cervix uteri and vitamin A. Br J Cancer 53 653-659.
201. GJ Matlashewski, S Tuck, D Pim, et al. (1987) Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7 961-963.
202. A Storey, M Thomas, A Kalita, et al. (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer [see comments]. Nature 393 229-234.
203. JM Ojeda, S Ampuero and P Rojas (2003) P53 codon 72 polymorphism and risk of cervical cancer. Biol Res 36 279-283.
204. M Qie, Y Zhang and J Wu (2002) Study on the relationship between cervical cancer and p53 codon 72 polymorphism [Chinese]. Hua-Hsi i Ko Ta Hsueh Hsueh Pao 33 274-275.
205. A Sifuentes-Alvarez and RM Reyes (2003) Risk factors for cervico-uterine cancer associated to HPV: p53 codon 72 polymorphism in women attending hospital care [Spanish]. Ginecol Obstet Mex 71 12-15.
206. MC Abba, LM Villaverde, MA Gomez, et al. (2003) The p53 codon 72 genotypes in HPV infection and cervical disease. Eur J Obstet Gynecol Reprod Biol 109 63-66.
207. M Cenci, D French, T Pisani, et al. (2003) P53 polymorphism at codon 72 is not a risk factor for cervical carcinogenesis in central Italy. Anticancer Res 23 1385-1387.
208. SH Jee, JE Lee and JS Park (2003) Polymorphism of codon 72 of p53 and environmental factors in the development of cervical cancer. Int J Gynaecol Obstet 80 69-70.
209. MT Goodman, K McDuffie, B Hernandez, et al. (2001) CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol Oncol 81 263-269.
210. CH Sierra-Torres, WW Au, CD Arrastia, et al. (2003) Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia. Environ Mol Mutagen 41 69-76.
211. SP Mathur, RS Mathur and RC Young (2000) Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer. Am J Reprod Immunol 44 222-230.
212. AJ Berger, A Baege, T Guillemette, et al. (2002) Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins. Am J Pathol 161 603-610.
213. X Wu, G Tortolero-Luna, H Zhao, et al. (2003) Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix. Clin Cancer Res 9 3356-3361.
214. NF Schlecht, S Kulaga, J Robitaille, et al. (2001) Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286 3106-3114.
215. GY Ho, RD Burk, S Klein, et al. (1995) Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia [comment]. J Natl Cancer Inst 87 1365-1371.
216. EL Franco (1997) Understanding the epidemiology of genital infection with oncogenic and nononcogenic human papillo-maviruses: A promising lead for primary prevention of cervical cancer [comment]. Cancer Epidemiol Biomarkers Prev 6 759-761.
217. NF Schlecht, RW Platt, E Duarte-Franco, et al. (2003) Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 95 1336-1343.
218. MC Rousseau, LL Villa, MC Costa, et al. (2003) Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities. Sex Transm Dis 30 581-587.
219. NF Schlecht, A Trevisan, E Duarte-Franco, et al. (2003) Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 103 519-524.
220. AM Josefsson, PK Magnusson, N Ylitalo, et al. (2000) Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: A nested case-control study [comment]. Lancet 355 2189-2193.
221. J Brisson, I Bairati, C Morin, et al. (1996) Determinants of persistent detection of human papillomavirus DNA in the uterine cervix. J Infect Dis 173 794-799.
222. DM Hernandez-Hernandez, L Ornelas-Bernal, M Guido-Jimenez, et al. (2003) Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women. Gynecol Oncol 90 310-317.
223. V Dalstein, D Riethmuller, JL Pretet, et al. (2003) Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study. Int J Cancer 106 396-403.
224. EL Franco, LL Villa, P Rahal and A Ruiz (1994) Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection. J Natl Cancer Inst 86 1558-1559.
225. HU Bernard (1994) Coevolution of papillomaviruses with human populations [review]. Trends Microbiol 2 140-143.
226. SY Chan, L Ho, CK Ong, et al. (1992) Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol 66 2057-2066.
227. L Ho, SK Tay, SY Chan and HU Bernard (1993) Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia. J Infect Dis 168 803-809.
228. T Yamada, CM Wheeler, AL Halpern, et al. (1995) Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 69 7743-7753.
229. LF Xi, LA Koutsky, DA Galloway, et al. (1997) Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia [comment]. J Natl Cancer Inst 89 796-802.
230. LL Villa, L Sichero, P Rahal, et al. (2000) Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81 2959-2968.
231. LF Xi, JJ Carter, DA Galloway, et al. (2002) Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev 11 343-351.
232. J Berumen, RM Ordonez, E Lazcano, et al. (2001) Asian-American variants of human papillomavirus 16 and risk for cervical cancer: A case-control study. J Natl Cancer Inst 93 1325-1330.
233. LL Villa (1997) Human papillomaviruses and cervical cancer [review]. Adv Cancer Res 71 321-341.
234. P Londesborough, L Ho, G Terry, et al. (1996) Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 69 364-368.
235. I Zehbe, G Voglino, H Delius, et al. (1998) Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms [letter; see comments]. Lancet 352 1441-1442.
236. HJ Bontkes, M van Duin, TD de Gruijl, et al. (1998) HPV 16 infection and progression of cervical intra-epithelial neoplasia: Analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 78 166-171.
237. I Nindl, K Rindfleisch, K Teller, et al. (1999) Cervical cancer, HPV 16 E6, variant genotypes, and serology [letter; comment]. Lancet 353 152.
238. X Hu, Z Guo, P Tianyun, et al. (1999) HPV typing and HPV16 E6-sequence variations in synchronous lesions of cervical squam-ous-cell carcinoma from Swedish patients. Int J Cancer 83 34-37.
239. CS Brady, MF Duggan-Keen, JA Davidson, et al. (1999) Human papillomavirus type 16 E6 variants in cervical carcinoma: Relationship to host genetic factors and clinical parameters. J Gen Virol 80 3233-3240.
240. PK Chan, AR Chang, JL Cheung, et al. (2002) Determinants of cervical human papillomavirus infection: Differences between high-and low-oncogenic risk types. J Infect Dis 185 28-35.
241. DR Lowy and IH Frazer (2003) Prophylactic human papillomavirus vaccines [review]. J Natl Cancer Inst Monogr (31), 111-116.
242. D Solomon (2003) Role of triage testing in cervical cancer screening [review]. J Natl Cancer Inst Monogr (31), 97-101.
243. J Cuzick, P Sasieni, P Davies, et al. (2000) A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: Summary and conclusions [review]. Br J Cancer 83 561-565.
244. SJ Goldie (2003) Public health policy and cost-effectiveness analysis [review]. J Natl Cancer Inst Monogr (31), 102-110.
245. ABS Miller (2003) Can screening for cervical cancer be improved, especially in developing countries? Int J Cancer 107 337-340.
246. AR Giuliano, M Papenfuss, M Nour, et al. (1997) Antioxidant nutrients: Associations with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 6 917-923.
247. LL Villa, HU Bernard, M Kast, et al. (2002) Past, present, and future of HPV research: Highlights from the 19th International Papillomavirus Conference-HPV2001 [review]. Virus Res 89 163-173.
248. NB Anderson (1999) Solving the puzzle of socioeconomic status and health: The need for integrated, multilevel, interdisciplinary research [review]. Ann N Y Acad Sci 896 302-312.
249. S Aral (1999) Elimination and reintroduction of a sexually transmitted disease: Lessons to be learned? [comment]. Am J Publ Health 89 995-997.
250. J Rotmensch, SD Yamada (2003) Neoplasms of the vulva and vagina. DW Kufe, RE Pollock, RR Weichselbaum, et al., (Eds) Cancer Medicine 6th ed. Hamilton, Ontario: BC Decker
251. JR Daling and KJ Sherman (1996) Cancer of the vulva and vagina. D Schottenfeld, D Schottenfeld (Eds) Cancer Epidemiology and Prevention New York: Oxford University Press
252. DM Parkin, SL Whelan, J Ferlay, et al. (1997) Cancer Incidence in Five Continents VII Lyon, France: IARC
253. SR Sturgeon, LA Brinton, SS Devesa and RJ Kurman (1992) In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol 166 1482-1485.
254. MM Madeleine, JR Daling and HK Tamini (2002) Vulva and vagina. EL Franco, TE Rohan (Eds) Cancer Precursors: Epidemiology, Detection, and Prevention New York: Springer-Verlag
255. HL Howe, PA Wingo, MJ Thun, et al. (2001) Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends [comment]. J Natl Cancer Inst 93 824-842.
256. F Levi, L Randimbison and C La Vecchia (1998) Descriptive epidemiology of vulvar and vaginal cancers in Vaud, Switzerland, 1974-1994. Ann Oncol 9 1229-1232.
257. T Iversen and S Tretli (1998) Intraepithelial and invasive squamous cell neoplasia of the vulva: Trends in incidence, recurrence, and survival rate in Norway. Obstet Gynecol 91 969-972.
258. RW Jones, J Baranyai and S Stables (1997) Trends in squamous cell carcinoma of the vulva: The influence of vulvar intraepithelial neoplasia. Obstet Gynecol 90 448-452.
259. AC Ansink, MR Krul, RA De Weger, et al. (1994) Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: Detection and prognostic significance. Gynecol Oncol 52 180-184.
260. BJ Monk, RA Burger, F Lin, et al. (1995) Prognostic significance of human papillomavirus DNA in vulvar carcinoma [review]. Obstet Gynecol 85 709-715.
261. AP Pinto, LB Signorello, CP Crum, et al. (1999) Squamous cell carcinoma of the vulva in Brazil: Prognostic importance of host and viral variables. Gynecol Oncol 74 61-67.
262. LA Brinton, PC Nasca, K Mallin, et al. (1990) Case-control study of cancer of the vulva. Obstet Gynecol 75 859-866.
263. JR Daling and KJ Sherman (1992) Relationship between human papillomavirus infection and tumours of anogenital sites other than the cervix [review]. IARC Scientific Publications (119), 223-241.
264. JJ Carter, MM Madeleine, K Shera, et al. (2001) Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res 61 1934-1940.
265. KJ Sherman, JR Daling, J Chu, et al. (1988) Multiple primary tumours in women with vulvar neoplasms: A case-control study. Br J Cancer 57 423-427.
266. SR Sturgeon, RG Ziegler, LA Brinton, et al. (1991) Diet and the risk of vulvar cancer. Ann Epidemiol 1 427-437.
267. KJ Sherman, JR Daling, J Chu, et al. (1991) Genital warts, other sexually transmitted diseases, and vulvar cancer. Epidemiology 2 257-262.
268. JR Daling, KJ Sherman, TG Hislop, et al. (1992) Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 135 180-189.
269. CP Crum (1992) Carcinoma of the vulva: Epidemiology and pathogenesis [review]. Obstet Gynecol 79 448-454.
270. RJ Kurman, T Toki and MH Schiffman (1993) Basaloid and warty carcinomas of the vulva: Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses [erratum appears in Am J Surg Pathol 1993;17:536.]. Am J Surg Pathol 17 133-145.
271. JS Park, RW Jones, MR McLean, et al. (1991) Possible etiologic heterogeneity of vulvar intraepithelial neoplasia: A correlation of pathologic characteristics with human papillomavirus detection by in situ hybridization and polymerase chain reaction. Cancer 67 1599-1607.
272. T Toki, RJ Kurman, JS Park, et al. (1991) Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: A clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 10 107-125.
273. ML Gillison and KV Shah (2003) Role of mucosal human papillomavirus in nongenital cancers [review]. J Natl Cancer Inst Monogr (31), 57-65.
274. CL Trimble, A Hildesheim, LA Brinton, et al. (1996) Heterogeneous etiology of squamous carcinoma of the vulva. Obstet Gynecol 87 59-64.
275. Y Sun, A Hildesheim, LA Brinton, et al. (1996) Human papillomavirus-specific serologic response in vulvar neoplasia. Gynecol Oncol 63 200-203.
276. A Hildesheim, CL Han, LA Brinton, et al. (1997) Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: Results from a seroepidemiological case-control study [see comments]. Obstet Gynecol 90 748-754.
277. T Bjorge, J Dillner, T Anttila, et al. (1997) Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers [comment]. BMJ 315 646-649.
278. MM Madeleine, JR Daling, JJ Carter, et al. (1997) Cofactors with human papillomavirus in a population-based study of vulvar cancer [erratum appears in J Natl Cancer Inst 1997;89:1896.]. J Natl Cancer Inst 89 1516-1523.
279. LA Brinton, PC Nasca, K Mallin, et al. (1990) Case-control study of in situ and invasive carcinoma of the vagina. Gynecol Oncol 38 49-54.
280. YC Choo and DG Anderson (1982) Neoplasms of the vagina following cervical carcinoma. Gynecol Oncol 14 125-132.
281. PG Rose, EE Herterick, JG Boutselis, et al. (1987) Multiple primary gynecologic neoplasms. Am J Obstet Gynecol 157 261-267.
282. JR Daling, MM Madeleine, SM Schwartz, et al. (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84 263-270.
283. H Ikenberg, M Runge, A Goppinger and A Pfleiderer (1990) Human papillomavirus DNA in invasive carcinoma of the vagina. Obstet Gynecol 76 432-438.
284. A Hildesheim, C-L Han, LA Brinton, et al. (1997) Sexually transmitted agents and risk of carcinoma of the vagina. Int J Gynecol Cancer 7 251-255.
285. L Barzon, S Pizzighella, L Corti, et al. (2002) Vaginal dysplastic lesions in women with hysterectomy and receiving radiotherapy are linked to high-risk human papillomavirus. J Med Virol 67 401-405.
286. JM Herman, HD Homesley and MB Dignan (1986) Is hysterectomy a risk factor for vaginal cancer? JAMA 256 601-603.
287. WC Williams and JM Herman (1990) Vaginal intraepithelial neoplasia: Methodologic problems in a case-control study. Fam Pract Res J 10 27-35.